JP2009530624A5 - - Google Patents

Download PDF

Info

Publication number
JP2009530624A5
JP2009530624A5 JP2009500679A JP2009500679A JP2009530624A5 JP 2009530624 A5 JP2009530624 A5 JP 2009530624A5 JP 2009500679 A JP2009500679 A JP 2009500679A JP 2009500679 A JP2009500679 A JP 2009500679A JP 2009530624 A5 JP2009530624 A5 JP 2009530624A5
Authority
JP
Japan
Prior art keywords
patient
sample
prostate cancer
molecular formula
mass
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009500679A
Other languages
English (en)
Japanese (ja)
Other versions
JP5612303B2 (ja
JP2009530624A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2007/000469 external-priority patent/WO2007109881A1/en
Publication of JP2009530624A publication Critical patent/JP2009530624A/ja
Publication of JP2009530624A5 publication Critical patent/JP2009530624A5/ja
Application granted granted Critical
Publication of JP5612303B2 publication Critical patent/JP5612303B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009500679A 2006-03-24 2007-03-23 患者における前立腺癌の健康状態等を判定するためにデータを得る方法 Expired - Fee Related JP5612303B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78548006P 2006-03-24 2006-03-24
US60/785,480 2006-03-24
PCT/CA2007/000469 WO2007109881A1 (en) 2006-03-24 2007-03-23 Biomarkers useful for diagnosing prostate cancer, and methods thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012259409A Division JP5502972B2 (ja) 2006-03-24 2012-11-28 前立腺癌を診断するために有用なバイオマーカー及びその方法

Publications (3)

Publication Number Publication Date
JP2009530624A JP2009530624A (ja) 2009-08-27
JP2009530624A5 true JP2009530624A5 (https=) 2010-05-06
JP5612303B2 JP5612303B2 (ja) 2014-10-22

Family

ID=38540744

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009500679A Expired - Fee Related JP5612303B2 (ja) 2006-03-24 2007-03-23 患者における前立腺癌の健康状態等を判定するためにデータを得る方法
JP2012259409A Expired - Fee Related JP5502972B2 (ja) 2006-03-24 2012-11-28 前立腺癌を診断するために有用なバイオマーカー及びその方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012259409A Expired - Fee Related JP5502972B2 (ja) 2006-03-24 2012-11-28 前立腺癌を診断するために有用なバイオマーカー及びその方法

Country Status (10)

Country Link
US (2) US8409794B2 (https=)
EP (2) EP2674435A3 (https=)
JP (2) JP5612303B2 (https=)
KR (1) KR20090006837A (https=)
CN (1) CN101454331A (https=)
AU (1) AU2007231487B2 (https=)
BR (1) BRPI0709176A2 (https=)
CA (1) CA2644330C (https=)
SG (1) SG170061A1 (https=)
WO (1) WO2007109881A1 (https=)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3003765B2 (ja) 1994-09-20 2000-01-31 株式会社デンソー チューブジョイント
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
WO2007081385A2 (en) 2006-01-11 2007-07-19 Raindance Technologies, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
EP2530167A1 (en) 2006-05-11 2012-12-05 Raindance Technologies, Inc. Microfluidic Devices
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
EP2077912B1 (en) 2006-08-07 2019-03-27 The President and Fellows of Harvard College Fluorocarbon emulsion stabilizing surfactants
JP5297379B2 (ja) * 2006-09-19 2013-09-25 メタボロン、インコーポレイテッド 前立腺癌のバイオマーカー及びそれを使用する方法
US20090075284A1 (en) * 2006-09-19 2009-03-19 The Regents Of The University Of Michigan Metabolomic profiling of prostate cancer
WO2008075664A1 (ja) * 2006-12-21 2008-06-26 Ajinomoto Co., Inc. 癌の評価方法、ならびに癌評価装置、癌評価方法、癌評価システム、癌評価プログラムおよび記録媒体
WO2008097559A2 (en) 2007-02-06 2008-08-14 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US8592221B2 (en) 2007-04-19 2013-11-26 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
US20100291690A1 (en) * 2007-11-07 2010-11-18 Lian Shan Methods for detecting or monitoring cancer using lpc as a marker
AU2008325187A1 (en) * 2007-11-07 2009-05-14 H. Lee Moffitt Cancer Center And Research Institute, Inc. Methods for detecting or monitoring cancer using LPC as a marker
US8710429B2 (en) * 2007-12-21 2014-04-29 The Board Of Regents Of The University Of Ok Identification of biomarkers in biological samples and methods of using same
WO2009110517A1 (ja) * 2008-03-04 2009-09-11 味の素株式会社 癌種の評価方法
JP5754137B2 (ja) * 2008-06-20 2015-07-29 味の素株式会社 前立腺癌の評価方法、前立腺癌評価装置、前立腺癌評価方法、前立腺癌評価プログラム、記録媒体、前立腺癌評価システム、および情報通信端末装置
AU2009270851A1 (en) * 2008-07-16 2010-01-21 Dana-Farber Cancer Institute, Inc. Signatures and PCDETERMINANTS associated with prostate cancer and methods of use thereof
EP4047367A1 (en) 2008-07-18 2022-08-24 Bio-Rad Laboratories, Inc. Method for detecting target analytes with droplet libraries
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
KR101018665B1 (ko) 2008-08-18 2011-03-04 재단법인서울대학교산학협력재단 전립선암 진단 방법 및 장치
US8399829B2 (en) 2008-12-18 2013-03-19 Quest Diagnostics Investments Incorporated Vitamin B2 detection by mass spectrometry
WO2010111231A1 (en) 2009-03-23 2010-09-30 Raindance Technologies, Inc. Manipulation of microfluidic droplets
US9500572B2 (en) 2009-04-30 2016-11-22 Purdue Research Foundation Sample dispenser including an internal standard and methods of use thereof
WO2010139711A1 (en) * 2009-06-04 2010-12-09 Metanomics Health Gmbh Means and methods for diagnosing prostate carcinomas
EP3124980A1 (en) * 2009-10-01 2017-02-01 Phenomenome Discoveries Inc. Mass spectrophotometric method to diagnose pancreatic cancer
US10520500B2 (en) 2009-10-09 2019-12-31 Abdeslam El Harrak Labelled silica-based nanomaterial with enhanced properties and uses thereof
CN102893157A (zh) * 2009-12-22 2013-01-23 密执安大学评议会 前列腺癌的代谢特征
US10837883B2 (en) 2009-12-23 2020-11-17 Bio-Rad Laboratories, Inc. Microfluidic systems and methods for reducing the exchange of molecules between droplets
EP2354794A1 (en) * 2010-01-29 2011-08-10 IMG Institut für medizinische Genomforschung Planungsgesellschaft M.B.H. Diagnosing prostate cancer relapse
EP4484577A3 (en) 2010-02-12 2025-03-26 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
WO2011140492A2 (en) * 2010-05-07 2011-11-10 Ut-Battelle, Llc System and method for extracting a sample from a surface
EP3955004B1 (en) * 2010-06-23 2024-05-29 University of Louisville Research Foundation, Inc. Use of fatty acids in methods for detecting cancer
US20130217647A1 (en) * 2010-07-28 2013-08-22 Metabolon, Inc. Biomarkers for Prostate Cancer and Methods Using the Same
US9562897B2 (en) 2010-09-30 2017-02-07 Raindance Technologies, Inc. Sandwich assays in droplets
EP3412778A1 (en) 2011-02-11 2018-12-12 Raindance Technologies, Inc. Methods for forming mixed droplets
WO2012112804A1 (en) 2011-02-18 2012-08-23 Raindance Technoligies, Inc. Compositions and methods for molecular labeling
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
EP3216872B1 (en) 2011-06-02 2020-04-01 Bio-Rad Laboratories, Inc. Enzyme quantification
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
WO2013120089A1 (en) 2012-02-10 2013-08-15 Raindance Technologies, Inc. Molecular diagnostic screening assay
MY193914A (en) 2012-03-05 2022-11-01 Oy Arctic Partners Ab Methods and apparatuses for predicting risk of prostate cancer and prostate gland volume
EP2844768B1 (en) 2012-04-30 2019-03-13 Raindance Technologies, Inc. Digital analyte analysis
US20150285805A1 (en) 2012-11-05 2015-10-08 Ospedale San Raffaele S.R.L. Biomarkers of multiple myeloma development and progression
US9176154B2 (en) 2012-12-12 2015-11-03 Bio-Rad Laboratories, Inc. Calibration process and system
US9733228B2 (en) 2013-01-31 2017-08-15 Purdue Research Foundation Methods of analyzing crude oil
WO2014120411A1 (en) * 2013-01-31 2014-08-07 Purdue Research Foundation Systems and methods for analyzing an extracted sample
WO2014172288A2 (en) 2013-04-19 2014-10-23 Raindance Technologies, Inc. Digital analyte analysis
JP6660291B2 (ja) * 2013-05-14 2020-03-11 セントジーン アーゲー ニーマン・ピック病の診断のための方法
WO2014209474A1 (en) 2013-06-25 2014-12-31 Purdue Research Foundation Mass spectrometry analysis of microorganisms in samples
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
WO2015103367A1 (en) 2013-12-31 2015-07-09 Raindance Technologies, Inc. System and method for detection of rna species
US12326453B2 (en) 2014-03-28 2025-06-10 Opko Diagnostics, Llc Compositions and methods for active surveillance of prostate cancer
DK3123381T3 (da) 2014-03-28 2023-11-27 Opko Diagnostics Llc Sammensætninger og fremgangsmåder relateret til diagnose af prostatacancer
US10879056B2 (en) * 2014-05-30 2020-12-29 ASTA, Co. Ltd Integrated disease diagnostic system using matrix-assisted laser desorption/ionization time-of-flight mass spectrometer
US10197551B2 (en) * 2014-05-30 2019-02-05 ASTA, Co. Ltd. Integrated disease diagnostic system using matrix-assisted laser desorption/ionization time-of-flight mass spectrometer
US9786478B2 (en) 2014-12-05 2017-10-10 Purdue Research Foundation Zero voltage mass spectrometry probes and systems
CN107960130A (zh) 2015-02-06 2018-04-24 普度研究基金会 探针、系统、盒及其使用方法
WO2016160545A1 (en) 2015-03-27 2016-10-06 Opko Diagnostics, Llc Prostate antigen standards and uses thereof
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
CN105424841B (zh) * 2015-12-25 2017-11-03 齐炼文 用于诊断冠状动脉粥样硬化的代谢标志物
JP2017203649A (ja) * 2016-05-09 2017-11-16 国立大学法人大阪大学 前立腺がん判定方法
US10006925B2 (en) 2016-05-30 2018-06-26 Universal Diagnostics, S. L. Methods and systems for metabolite and/or lipid-based detection of colorectal cancer and/or adenomatous polyps
WO2018016645A1 (ja) * 2016-07-22 2018-01-25 国立大学法人秋田大学 新規リン脂質およびその利用ならびにリン脂質分離測定法の開発
US10319574B2 (en) * 2016-08-22 2019-06-11 Highland Innovations Inc. Categorization data manipulation using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometer
US11073522B2 (en) 2016-10-03 2021-07-27 Lincoln Memorial University Structural validation of very long chain dicarboxylic acids
WO2018158801A1 (ja) * 2017-02-28 2018-09-07 株式会社島津製作所 スペクトルデータの特徴抽出装置および方法
US10998178B2 (en) 2017-08-28 2021-05-04 Purdue Research Foundation Systems and methods for sample analysis using swabs
CN118942699B (zh) * 2024-07-23 2025-04-25 中日友好医院(中日友好临床医学研究所) 一种肺动脉高压预测方法、系统
CN120766944A (zh) * 2025-06-09 2025-10-10 宁波大学附属第一医院 尿液小细胞外囊泡脂质标志物联合临床参数在前列腺癌风险分级诊断产品中的应用
CN121096509B (zh) * 2025-11-11 2026-02-10 山东第一医科大学附属省立医院(山东省立医院) 磷脂酰肌醇和磷脂酰甘油作为颅内动脉粥样硬化进展预测的代谢标志物的应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4813171A (en) 1987-11-24 1989-03-21 Herbert Cooper Power-operated lateral actuator for a fishing outrigger
US4953328A (en) 1989-05-24 1990-09-04 Sewell Scott R Air conditioning compressor sectionalized cover
AT399867B (de) 1990-01-11 1995-08-25 Lisec Peter Anlage zur herstellung von isolierglasscheiben
US5233640A (en) 1991-01-11 1993-08-03 Detection Systems, Inc. Security system with backup dialer
IT1252437B (it) 1991-07-19 1995-06-14 Gd Spa Metodo e dispositivo per la piegatura di sbozzati di incarto lungo linee di piegatura pre-indebolite
CA2089503C (en) 1992-02-19 1996-09-03 Marcus Mintz Casing structure for encasing meat products
US5213480A (en) 1992-06-08 1993-05-25 Graco, Inc. Pump lift mechanism
US5313123A (en) 1992-11-23 1994-05-17 Leonid Simuni Automobile having the magnetohydrodynamic engine
DE4306614A1 (de) 1993-03-03 1994-09-08 Bayer Ag Verfahren zur Wiederverwertung von Lackabfällen
US5441589A (en) 1993-06-17 1995-08-15 Taurus Impressions, Inc. Flat bed daisy wheel hot debossing stamper
CA2150938C (en) 1993-10-28 1999-09-07 Ricardo Lim Demodulator logic unit adaptable to multiple data protocols
US5434195A (en) 1994-06-23 1995-07-18 The Dow Chemical Company Extruded, open-cell alkenyl aromatic polymer foam and process for making
US5653394A (en) 1995-09-28 1997-08-05 Highline Mfg. Inc. Disintegration of baled crop materials
US5673546A (en) 1995-12-26 1997-10-07 Abraham; Carl J. Non-slip shoelaces
US5858681A (en) 1996-06-17 1999-01-12 Children's Medical Center Method for prognosis of prostate cancer
KR20010005550A (ko) * 1997-03-21 2001-01-15 아타르진 테크놀로지스 인코퍼레이티드 리소포스포리피드 농도 변화와 연관된 암 감지 방법
WO2001025791A2 (en) 1999-10-07 2001-04-12 Ciphergen Biosystems, Inc. Prostate cancer marker proteins
CA2298181C (en) 2000-02-02 2006-09-19 Dayan Burke Goodnough Non-targeted complex sample analysis
CN1426536A (zh) 2000-03-20 2003-06-25 东弗吉尼亚医学院 前列腺癌标记
US20020009740A1 (en) * 2000-04-14 2002-01-24 Rima Kaddurah-Daouk Methods for drug discovery, disease treatment, and diagnosis using metabolomics
BR0115689A (pt) 2000-11-28 2004-02-10 Wyeth Corp Análise de expressão de inibidor de diferenciação de ácidos nucléicos e polipeptìdeos úteis na diagnose e tratamento de câncer da próstata
US20030228639A1 (en) * 2001-03-19 2003-12-11 Wright George L Prostate cancer markers
US6919176B2 (en) * 2001-05-07 2005-07-19 Amgen Inc. Polypeptides and nucleic acids associated with cancer
US20040203012A1 (en) * 2001-05-25 2004-10-14 Eleftherios Diamandis Method of detecting and monitoring prostate and ovarian cancers
WO2003091695A2 (en) * 2002-04-26 2003-11-06 The Johns Hopkins University Identification of biomarkers for detecting prostate cancer
JP2006509186A (ja) 2002-05-10 2006-03-16 イースタン バージニア メディカル スクール 前立腺癌バイオマーカー
AUPS282602A0 (en) * 2002-06-07 2002-06-27 Garvan Institute Of Medical Research Method of inhibiting cell proliferation
US20050244973A1 (en) * 2004-04-29 2005-11-03 Predicant Biosciences, Inc. Biological patterns for diagnosis and treatment of cancer
US20070009970A1 (en) 2005-07-08 2007-01-11 Predicant Biosciences, Inc. Biological patterns for diagnosis and treatment of cancer

Similar Documents

Publication Publication Date Title
JP2009530624A5 (https=)
Kurabe et al. Accumulated phosphatidylcholine (16: 0/16: 1) in human colorectal cancer; possible involvement of LPCAT 4
Nilsson et al. Fine mapping the spatial distribution and concentration of unlabeled drugs within tissue micro-compartments using imaging mass spectrometry
Gerbig et al. Analysis of colorectal adenocarcinoma tissue by desorption electrospray ionization mass spectrometric imaging
Mir et al. LC–MS-based serum metabolomic analysis reveals dysregulation of phosphatidylcholines in esophageal squamous cell carcinoma
JP5502972B2 (ja) 前立腺癌を診断するために有用なバイオマーカー及びその方法
Chaurand et al. Molecular imaging of thin mammalian tissue sections by mass spectrometry
JP2009528517A5 (https=)
Lopes et al. Metabolomic strategies involving mass spectrometry combined with liquid and gas chromatography
Barry et al. Mapping antiretroviral drugs in tissue by IR-MALDESI MSI coupled to the Q Exactive and comparison with LC-MS/MS SRM assay
Jha et al. Spatial neurolipidomics—MALDI mass spectrometry imaging of lipids in brain pathologies
Saha et al. Direct analysis of anabolic steroids in urine using Leidenfrost phenomenon assisted thermal desorption-dielectric barrier discharge ionization mass spectrometry
US11428682B2 (en) Quantitation of tamoxifen and metabolites thereof by mass spectrometry
Gustafsson et al. Metabolite mapping by consecutive nanostructure and silver‐assisted mass spectrometry imaging on tissue sections
Zeng et al. In situ localization of lipids on mouse kidney tissues with acute cadmium toxicity using atmospheric pressure-MALDI mass spectrometry imaging
Slijkhuis et al. MALDI versus DESI mass spectrometry imaging of lipids in atherosclerotic plaque
Estrada et al. Regional phospholipid analysis of porcine lens membranes by matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry
Nabi et al. Mass spectrometry in the lipid study of cancer
Zhu et al. Diastereomer recognition of three pairs of tetracyclines by electrospray ionization mass spectrometry
Moritz et al. The Potential of Ultrahigh Resolution MS (FTICR‐MS) in Metabolomics
Garrett et al. Tandem mass spectrometric methods for phospholipid analysis from brain tissue
Sitoe et al. Contribution of mass spectrometry to the study of antimalarial agents
Barnes et al. Accurate characterization of carcinogenic DNA adducts using MALDI tandem time-of-flight mass spectrometry
JP6174689B2 (ja) 慢性弁膜疾患を診断するための方法
Nikiforov et al. Detection of Disease by Analysis of Volatile Organic Compounds: II. Direct Sample Injection Mass Spectrometry